CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Karnan S, Ota A, Murakami H, Rahman ML, Wahiduzzaman M, Hasan MN, Vu LQ, Hanamura I, Inoko A, Riku M, Ito H, Kaneko Y, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y
Cell Death Discov. 2023 Jul 21;9(1):257. doi: 10.1038/s41420-023-01552-5.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.